| [1] |
Merrimen JL, Jones G, Walker D,et al. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma [J]. J Urol,2009,182(2):485-90.
|
| [2] |
Schonfeld SJ, Curtis RE, Anderson WF, et al. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status[J]. Cancer Causes Control， 20 12,23(10):1721-8.
|
| [3] |
Klein CA. Parallel progression of primary tumours and metastases[J]. Nat Rev Cancer,2009,9(4):302-12.
|
| [4] |
Christofori G. New signals from the invasive front [J]. Nature 20 06,441(7092):444-50.
|
| [5] |
Noël A, Gilles C, Foidart JM.Invasion and metastatic dissemination in breast cancer: mechanisms[J]. Rev Med Liege, 20 11,66(5-6):274-8.
|
| [6] |
Langley RR, Fidler IJ. The seed and soil hypothesis revisited-- the role of tumor-stroma interactions in metastasis to different organs[J]. Int J Cancer,2011,128(11):2527-35.
|
| [7] |
Hiratsuka S, Watanabe A, Aburatani H, et al. Tumourmediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis[J]. Nat Cell Biol,2006,8(12):1369-75.
|
| [8] |
Maller O, Martinson H, Schedin P. Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland[J].J Mammary Gland Biol Neoplasia,2010,15(3):301-18.
|
| [9] |
Elkabets M, Gifford AM, Scheel C,et al. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice [J].J Clin Invest, 20 11,121(2):784-99.
|
| [10] |
Siletz A, Kniazeva E, Jeruss JS, et al. Transcription factor networks in invasion-promoting breast carcinoma-associated fi broblasts[J]. Cancer Microenviron,2013,6(1):91-107.
|
| [11] |
Kalluri R, Zeisberg M. Fibroblasts in cancer[J]. Nat Rev Cancer, 20 06,6(5):392-401.
|
| [12] |
Hu M, Yao J, Carroll DK, et al. Regulation of in situ to invasive breast carcinoma transition[J]. Cancer Cell,2008,13(5):394-406.
|
| [13] |
Huang CY, Feng CH, Hsiao YC, et al. Burn scar carcinoma[J].J Dermatolog Treat,2010,21(6):350-6.
|
| [14] |
Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development[J]. Annu Rev Pathol,2006,1:119-50.
|
| [15] |
Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments[J]. Cancer Res,2006,66(2):605-12.
|
| [16] |
Morandi A, Barbetti V, Riverso M,et al. The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines[J]. PLoS One,2011,6(11): e27450.
|
| [17] |
Sun ZK,Liu SC,Yao ZX. STAT3 activation of tumor-associated macrophages is associated with various cytokines and prognostic factors in breast cancer[J]. Zhong Liu, 2009,29(1):65-8.[孙正魁, 刘胜春, 姚榛祥. 乳腺癌中肿瘤相关巨噬细胞STAT3激活与多 种细胞因子及预后因素有关[J]. 肿瘤, 2009,29(1):65-8.]
|
| [18] |
Qian B, Deng Y, Im JH, et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth[J]. PLoS One, 2009,4(8):e6562.
|
| [19] |
Wang R, Zhang J, Chen S, et al. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression[J]. Lung Cancer, 2011,74(2):188-96.
|
| [20] |
Bolat F, Kayaselcuk F, Nursal TZ, et al. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters[J].J Exp Clin Cancer Res, 2006,25(3):365-72.
|
| [21] |
Puig-Kröger A, Sierra-Filardi E, Domínguez-Soto A, et al. Folate receptor beta is expressed by tumor-associated macrophagesand constitutes a marker for M2 anti-inflammatory/regulatory macrophages [J].Cancer Res, 2009,69(24):9395-403.
|
| [22] |
Eubank TD, Roberts RD, Khan M,et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumoreducated macrophages[J]. Cancer Res, 2009,69(5):2133-40.
|
| [23] |
Green CE, Liu T, Montel V,et al. Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization[J]. PLoS One, 20 09,4(8):e6713.
|
| [24] |
Hagemann T, Wilson J, Kulbe H, et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK[J].J Immunol, 2005,175(2):1197-205.
|
| [25] |
Weller K, Foitzik K, Paus R, et al. Mast cells are required for normal healing of skin wounds in mice[J]. FASEB J, 20 06,20(13):2366-8.
|
| [26] |
Xiang M, Gu Y, Zhao F, et al. Mast cell tryptase promotes breast cancer migration and invasion[J]. Oncol Rep, 2010,23(3):615-9.
|
| [27] |
Li Q ,Yang M ,Cao GM. Study of the relationship between the expression of Mass Cells and lymph node metastases and lymphangiogenesis in invasive ductal carcinoma[J]. Hainan Yi Xue, 2012,23(9):7-9.[黎晴, 杨梅, 曹桂明. 肥大细胞与乳腺浸润 性导管癌淋巴结转移及淋巴管生成的关系探讨[J]. 海南医学, 20 12,23(9):7-9.]
|
| [28] |
Della Rovere F, Granata A, Monaco M,et al. Phagocytosis of cancer cells by mast cells in breast cancer[J]. Anticancer Res, 20 09,29(8):3157-61.
|
| [29] |
Samoszuk M, Corwin MA. Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer[J]. Int J Cancer, 2003,107(1):159-63.
|
| [30] |
Crivellato E, Nico B, Ribatti D. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis[J]. Cancer Lett, 2008,269(1):1-6.
|
| [31] |
Hynes RO. The extracellular matrix: not just pretty fibrils[J]. Science,2009,326(5957):1216-9.
|
| [32] |
Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer[J]. Dis Model Mech, 2011,4(2):165-78.
|
| [33] |
Liang X. EMT: new signals from the invasive front[J]. Oral Oncol, 2011,47(8):686-7.
|
| [34] |
Handerson T, Camp R, Harigopal M, et al. Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma[J]. Clin Cancer Res, 20 05,11(8):2969-73.
|
| [35] |
Zhou YH, Liu XZ, Zhou SF. The Relationship of LN-R and uPA in Invasive Ductal Breast Cancer [J]. Zhongguo Lin Chuang Yi Xue, 2009,16(5):676-8. [周云海, 刘学忠, 周士福. 层粘连蛋白受 体、尿激酶型纤溶酶原激活物在乳腺浸润性导管癌中的表达 及其相关性[J]. 中国临床医学, 2009,16(5):676-8].
|
| [36] |
Oloumi A, Maidan M, Lock FE, et al. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development [J]. Breast Cancer Res 2010,12(3):R38.
|
| [37] |
Foubert P, Varner JA. Integrins in tumor angiogenesis and lymphangiogenesis[J]. Methods Mol Biol, 2012,757:471-86.
|
| [38] |
Dittrich A, Quaiser T, Khouri C,et al. Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling [J]. Mol Biosyst,2012,8(8):2119-34. .
|
| [39] |
Ginestier C, Liu S, Diebel ME, et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts[J].J Clin Invest, 2010,120(2):485-97.
|
| [40] |
Srabovi? N, Mujagi? Z, Mujanovi? -Mustedanagi? J,et al. Interleukin 18 expression in the primary breast cancer tumour tissue[J]. Med Glas(Zenica),2011,8(1):109-15.
|
| [41] |
Wang K, Grivennikov SI, Karin M. Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases[J]. Ann Rheum Dis, 2012, 72 Suppl 2:ii100-3.
|
| [42] |
McAuliffe PF, Meric-Bernstam F, Mills GB,et al. Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis[J]. Clin Breast Cancer, 2010,10 Suppl 3:S59-65.
|
| [43] |
Liu M, Sakamaki T, Casimiro MC, et al. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion[J]. Cancer Res, 20 10,70(24):10464-73.
|
下载:
